Xiong Xie
No. 19A Yuquan Road
Yuquan, 100049, China
Yuquan, 100049, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Exploring chemical space based on Transformation to design broad-spectrum 3CLpro inhibitors against coronavirus.
Journal: European journal of medicinal chemistry
Published: April 22, 2026
Discovery, Optimization, and Evaluation of Novel ANGPTL3 Modulators for the Treatment of Hyperlipidemia.
Journal: Journal of medicinal chemistry
Published: September 16, 2025
Development of Orally Bioavailable Octahydroindole-Based Peptidomimetic Derivative as a Broad-Spectrum Inhibitor against HCoV-OC43 and SARS-CoV-2.
Journal: Journal of medicinal chemistry
Published: May 22, 2025
Discovery of Novel Sulfonylurea NLRP3 Inflammasome Inhibitor for the Treatment of Multiple Inflammatory Diseases.
Journal: Journal of medicinal chemistry
Published: March 20, 2025
Research progress on critical viral protease inhibitors for coronaviruses and enteroviruses.
Journal: Bioorganic & medicinal chemistry letters
Published: October 29, 2024
Substrate recognition and cleavage mechanism of the monkeypox virus core protease.
Journal: Nature
Published: October 08, 2024
Palladium(II)-Catalyzed Tandem γ-C(sp2)-H Arylation and Cyclization for the Construction of Natural Product-Like Polycyclic Fused ortho-Quinone Scaffolds.
Journal: Organic letters
Published: April 12, 2024
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1.
Journal: Signal transduction and targeted therapy
Published: July 12, 2023
Synthesis of maleimide-braced peptide macrocycles and their potential anti-SARS-CoV-2 mechanisms.
Journal: Chemical communications (Cambridge, England)
Published: December 22, 2022
Structure-Based Design of Tropane Derivatives as a Novel Series of CCR5 Antagonists with Broad-Spectrum Anti-HIV-1 Activities and Improved Oral Bioavailability.
Journal: Journal of medicinal chemistry
Published: December 06, 2022
In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2.
Journal: Antiviral research
Published: July 24, 2022
Novel Sphingosine Kinase 1 Inhibitor Suppresses Growth of Solid Tumor and Inhibits the Lung Metastasis of Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: April 19, 2022
Last Updated: 09/26/2026